James C. Mullen, Director at Editas Medicine, Inc. (EDIT), bought 10,000 shares at $38.03 ($380K) on 2018-05-18, disclosed to the SEC on 2018-05-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| EDIT | BUY | 2021-03-04 | $1.2M | — | Filing → |
| PODD | BUY | 2017-11-14 | $169K | — | Filing → |
| PKI | SELL | 2014-11-17 | $389K | — | Filing → |